{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-001945","form_type":"8-K","ticker":"ACTU","cik":"0001652935","company_name":"ACTUATE THERAPEUTICS, INC.","filed_at":"2025-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.317865+00:00","generated_at":"2026-05-24T03:07:49.212870+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Actuate Therapeutics enters $50M equity line with B. Riley, can sell shares at 3% VWAP discount","bullets":["Company may sell up to $50M of common stock to B. Riley Principal Capital II over 36 months at a 3% discount to VWAP.","Sales are at Actuate's sole discretion; no obligation to sell any shares under the agreement.","Beneficial ownership by B. Riley capped at 4.99%; exchange cap of 19.99% of shares outstanding unless higher threshold price met.","Actuate paid a cash commitment fee of up to $500,000 (1% of facility) and will reimburse legal fees.","Proceeds intended for working capital and general corporate purposes; company retains right to terminate at any time with 10 trading days' notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-001945","json":"https://secwatch.observer/filing/0001683168-25-001945.json","markdown":"https://secwatch.observer/filing/0001683168-25-001945.md","text":"https://secwatch.observer/filing/0001683168-25-001945.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1652935/000168316825001945/0001683168-25-001945-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1652935/000168316825001945/actuate_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T03:07:49.212870+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}